Disc Medicine, Inc.2024财年第二财季实现净利润-26.35百万美元，同比减少65.20%

自选股智能写手08-18

8月18日，Disc Medicine, Inc.（IRON.US）公布财报，公告显示公司2024财年第二财季净利润为-26.35百万美元，同比减少65.20%；其中营业收入为0.00美元，每股基本收益为-1.03美元。从资产负债表来看，Disc Medicine, Inc.（IRON.US）总负债21.39百万美元，其中短期债务--，资产负债比为0.24，流动比率为0.26。机构评级：截至...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2460736669?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-18 00:04","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2460736669","market":"us","top_or_hot":-1,"title":"Disc Medicine, Inc.2024财年第二财季实现净利润-26.35百万美元，同比减少65.20%","media":"自选股智能写手","content":"<div>\n<p>8月18日，Disc Medicine, Inc.（IRON.US）公布财报，公告显示公司2024财年第二财季净利润为-26.35百万美元，同比减少65.20%；其中营业收入为0.00美元，每股基本收益为-1.03美元。从资产负债表来看，Disc Medicine, Inc.（IRON.US）总负债21.39百万美元，其中短期债务--，资产负债比为0.24，流动比率为0.26。机构评级：截至...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800070695a1682c&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Disc Medicine, Inc.2024财年第二财季实现净利润-26.35百万美元，同比减少65.20%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDisc Medicine, Inc.2024财年第二财季实现净利润-26.35百万美元，同比减少65.20%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-18 00:04 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800070695a1682c&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月18日，Disc Medicine, Inc.（IRON.US）公布财报，公告显示公司2024财年第二财季净利润为-26.35百万美元，同比减少65.20%；其中营业收入为0.00美元，每股基本收益为-1.03美元。从资产负债表来看，Disc Medicine, Inc.（IRON.US）总负债21.39百万美元，其中短期债务--，资产负债比为0.24，流动比率为0.26。机构评级：截至...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800070695a1682c&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IRON","symbol_name":"Disc Medicine","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800070695a1682c&s=b","article_id":"2460736669","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800070695a1682c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2460736669","pubTimestamp":1723910669,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"8月18日，Disc Medicine, Inc.公布财报，公告显示公司2024财年第二财季净利润为-26.35百万美元，同比减少65.20%；其中营业收入为0.00美元，每股基本收益为-1.03美元。机构评级：截至2024年8月18日，当前有9家机构对Disc Medicine, Inc.目标价做出预测，其中目标均价为65.11美元，其中最低目标价为40.00美元，最高目标价为85.00美元。Disc Medicine 致力于开发治疗方法，为许多患有血液疾病的患者提供帮助并带来希望。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"IRON":"Disc Medicine"},"translate_title":"Disc Medicine, Inc. achieved net profit of-US $26.35 million in the second fiscal quarter of fiscal year 2024, a year-on-year decrease of 65.20%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IRON":1},"content_text":"8月18日，Disc Medicine, Inc.（IRON.US）公布财报，公告显示公司2024财年第二财季净利润为-26.35百万美元，同比减少65.20%；其中营业收入为0.00美元，每股基本收益为-1.03美元。从资产负债表来看，Disc Medicine, Inc.（IRON.US）总负债21.39百万美元，其中短期债务--，资产负债比为0.24，流动比率为0.26。机构评级：截至2024年8月18日，当前有9家机构对Disc Medicine, Inc.目标价做出预测，其中目标均价为65.11美元，其中最低目标价为40.00美元，最高目标价为85.00美元。公司简介：Disc Medicine Inc 是一家临床阶段的生物制药公司，致力于改变血液疾病患者的生活。 该公司正在构建一系列影响红细胞生物学基本途径的创新治疗候选药物。 Disc Medicine 致力于开发治疗方法，为许多患有血液疾病的患者提供帮助并带来希望。 该公司已整合了一系列临床和临床前候选产品，旨在改变与红细胞形成和功能相关的基本生物途径，特别是血红素生物合成和铁稳态。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2460736669"}